missing translation for 'onlineSavingsMsg'
Learn More

R&D Systems™ I-BET 762

Catalog No. 18054232
Ansicht ändern
Click to view available options
Menge:
5 mg
25 mg
Packungsgröße:
25 Milligramm
5 Milligramm
2 product options available for selection
Product selection table with 2 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Menge Packungsgröße
18054232 5 mg 5 Milligramm
18094322 25 mg 25 Milligramm
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 2 options available.
2 options
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen
Catalog No. 18054232 Lieferant R&D Systems™ Lieferanten-Nr. 6521/5
 Eingeschränkter Artikel
Estimated Shipment: 24-11-2026
Zum Warenkorb hinzufügen
Zum Warenkorb hinzufügen

missing translation for 'validMainframeMsg'

This item is not returnable. View return policy

A Tocris product, part of R&D Systems. Potent and high affinity BET bromodomain inhibitor; anti-inflammatory; orally bioavailable.

I-BET 762 is a potent and high affinity BET bromodomain inhibitor (IC50 = 32.5 - 42.5 nM; Kd = 50.5 - 61.3 nM). Inhibits myeloma cell proliferation. Attenuates transcription of oncogenic MYC and suppresses key inflammatory genes. Exhibits efficacy in a range of oncology and immunoinflammatory models. Displays antiproliferative effect in vitro and in vivo. Orally bioavailable.
TRUSTED_SUSTAINABILITY

Specifications

Chemischer Name oder Material (4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide
CAS 1260907-17-2
Menge 5 mg
Produktlinie Tocris
Ziel Bromodomain Inhibitors
Summenformel C22H22ClN5O2
Reinheit 0.98
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.